KeyanooshHosseinzadehMD
Radiology • Winston Salem, NCAssistant Professor, Radiology, University of Pittsburgh School of Medicine
Are you Dr. Hosseinzadeh?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 35 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
S Hawthorne Rd
Winston Salem, NC 27157Phone+1 336-716-2255
Summary
- Dr. Keyanoosh Hosseinzadeh, MD is a board certified radiologist in Winston Salem, North Carolina. He is currently licensed to practice medicine in North Carolina, Pennsylvania, and Maryland. He is affiliated with Wake Forest Baptist Health-Lexington Medical Center and is an Assistant Professor at University of Pittsburgh School of Medicine.
Education & Training
University of Western OntarioClass of 1992
Certifications & Licensure
NC State Medical License 2013 - 2025
PA State Medical License 2005 - 2014
MD State Medical License 1999 - 2006
DC State Medical License 1997 - 2004- American Board of Radiology Diagnostic Radiology
Publications & Presentations
PubMed
- 118 citationsSafety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, ope...Angela Tatiana Alistar, Bonny Morris, Rodwige Desnoyer, Heidi D. Klepin, Keyanoosh Hosseinzadeh
The Lancet. Oncology. 2017-06-01 - 21 citationsMR imaging of the retrorectal–presacral tumors: an algorithmic approachHooman Hosseini-Nik, Keyanoosh Hosseinzadeh, Rajesh Bhayana, Kartik S. Jhaveri
Abdominal Imaging. 2015-03-24 - 96 citationsImaging of posttransplantation lymphoproliferative disorder after solid organ transplantation.Amir A. Borhani, Keyanoosh Hosseinzadeh, Omar Almusa, Alessandro Furlan, Michael A. Nalesnik
Radiographics. 2009-07-01
Authored Content
- ACR Appropriateness Criteria® Pretreatment Staging of Muscle-Invasive Bladder CancerMay 2018
- ACR Appropriateness Criteria® Pretreatment Staging of Muscle-Invasive Bladder CancerMay 2018
